ClinicalTrials.Veeva

Menu

Evaluation of Egg Consumption and Its Enrichment With Annatto on Cardiovascular Risk and Satiety in Healthy Adults (EGGANT)

U

Universidad de Antioquia

Status

Completed

Conditions

Healthy Volunteers

Treatments

Dietary Supplement: Annatto-enriched egg
Dietary Supplement: Whole egg
Dietary Supplement: Egg whites - Control

Study type

Interventional

Funder types

Other

Identifiers

NCT05088577
111580763245 (Other Grant/Funding Number)
754-2018

Details and patient eligibility

About

Healthy adult volunteers (n= 105; 18-59 years) were randomly allocated to consume daily for 8 weeks, either two whole eggs (egg group), two whole eggs added with annatto (annatto-enriched egg group), or two egg whites (control). Volunteers were asked to continue with the habitual physical activity and diet, except for the consumption of additional eggs, egg whites or annatto.

It is hypothesized that participants consuming eggs would have a less atherogenic lipid profile, feel more satisfied and increase antioxidant levels in blood, compared to the control group. Participants in the annatto-enriched egg group would have greater antioxidant capacity than the egg group and compared to control.

Enrollment

105 patients

Sex

All

Ages

18 to 59 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age: 18-59 years
  • Body Mass Index (BMI): 18,5 - 29,9 kg/m2
  • Healthy volunteers
  • Good disposition to consume either eggs, egg whites or eggs added with annatto
  • To have signed the informed consent

Exclusion criteria

  • Fasting blood triglycerides > 500mg/dL, Total Cholesterol > 240mg/dL, glucose > 126mg/dL or diabetes.
  • Blood pressure: >140/90 mmHg.
  • History or having any of the following: liver, kidney, or heart disease, cancer, endocrine or gastrointestinal disorders -especially those that limit food absorption.
  • Use of medications to lower blood lipids or glucose.
  • Consumption of multivitamins or nutraceuticals.
  • Plan to lose body weight, pregnancy or breastfeeding.
  • Any known allergy or intolerance to eggs or annatto.

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

105 participants in 3 patient groups, including a placebo group

Whole egg
Experimental group
Description:
Two whole eggs (50g each) to be eaten daily during 8 weeks
Treatment:
Dietary Supplement: Whole egg
Annatto-enriched egg
Experimental group
Description:
Two whole eggs (50g each) enriched with annatto (Bixa orellana L.) to be eaten daily during 8 weeks. Dose of annatto: 1,2 mg bixin/kg of body weight.
Treatment:
Dietary Supplement: Annatto-enriched egg
Egg whites - Control
Placebo Comparator group
Description:
Two egg whites to be eaten daily during 8 weeks
Treatment:
Dietary Supplement: Egg whites - Control

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems